| Bioactivity | Asparaginase Erwinia chrysanthemi (Crisantaspase) is a specific asparaginase with anti-acute lymphoblastic leukemia (ALL) activity. Asparaginase Erwinia chrysanthemi also depletes Glutamine to inhibit the growth of hepatocellular tumors in a mouse model[1][2]. |
| Name | Asparaginase Erwinia chrysanthemi |
| CAS | 1349719-22-7 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tong WH, et al. Back to the future: the amazing journey of the therapeutic antileukemia enzyme asparaginase Erwinia chrysanthemi. Haematologica. 2023 Jul 20. [2]. Chiu M, et al. Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. Br J Cancer. 2014 Sep 9;111(6):1159-67. |
Asparaginase Erwinia chrysanthemi
CAS: 1349719-22-7 F: W:
Asparaginase Erwinia chrysanthemi (Crisantaspase) is a specific asparaginase with anti-acute lymphoblastic leukemia (ALL
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.